Edition:
United Kingdom

Profile: IPCA Laboratories Ltd (IPCA.NS)

IPCA.NS on National Stock Exchange of India

979.00INR
11:24am BST
Change (% chg)

Rs13.70 (+1.42%)
Prev Close
Rs965.30
Open
Rs977.00
Day's High
Rs987.60
Day's Low
Rs975.70
Volume
142,908
Avg. Vol
190,386
52-wk High
Rs1,046.00
52-wk Low
Rs599.95

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.

Company Address

IPCA Laboratories Ltd

142 AB, Kandivli Industrial Esta
Kandivli (West)
MUMBAI     400067
P: +9122.66474747
F: +9122.66474579

Company Web Links